2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$131.08+$0.87 (+0.67%)
Price as of Aug 03, 2026 5:01 AM EDT- $161.7BMarket Cap
- 18.04%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$131.08+$0.87 (+0.67%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $130.21 | ||
Change | -$1.07 (-0.82%) | ||
Open | $130.23 | ||
High | $130.88 | ||
Low | $128.76 | ||
Previous Close | $131.28 | ||
Volume | 6,499,876 | ||
30-Day Average Volume | 6,657,925 | ||
1-Week Change | 0.70% | ||
1-Month Change | 3.06% | ||
1-Year Change | 18.04% | ||
3-Year Change | 88.75% | ||
5-Year Change | 128.85% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $56.3B | ||
Market Cap | $161.7B | ||
Enterprise Value | $176.2B | ||
Period: QTR TTM FY | |||
Revenue | $6.9B | ||
Net Income | $2.0B | ||
Free Cash Flow | $2.4B | ||
EBIT | $2.6B | ||
EBITDA | $2.7B | ||
Net Working Capital | $9.2B | ||
EPS | $1.61 | ||
Enterprise Value/EBITDA | 66 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 7 | ||
P/E | 81 | ||
PEG | -11 | ||
Price/Free Cash Flow | 67 | ||
Price/Operating Cash Flow | 64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.52% | ||
Trailing Annual Dividend Yield | 2.47% | ||
Ex-Dividend Date | 06/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield